THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 95 filers reported holding THERAVANCE INC in Q4 2015. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $17,976,000 | -75.3% | 2,503,600 | -37.8% | 0.71% | -69.2% |
| Q2 2015 | $72,763,000 | +14.9% | 4,026,736 | 0.0% | 2.30% | +10.4% |
| Q1 2015 | $63,300,000 | +11.1% | 4,026,736 | 0.0% | 2.08% | -12.6% |
| Q4 2014 | $56,978,000 | +82.1% | 4,026,736 | +119.9% | 2.38% | +110.0% |
| Q3 2014 | $31,293,000 | -30.7% | 1,831,099 | +20.7% | 1.14% | -9.1% |
| Q2 2014 | $45,182,000 | – | 1,517,208 | – | 1.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baupost Group | 20,395,056 | $607,365,000 | 9.89% |
| Realm Partners LLC | 301,521 | $8,979,000 | 3.75% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 2,805,837 | $83,558,000 | 2.52% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 7,447,743 | $221,794,000 | 2.27% |
| SECTORAL ASSET MANAGEMENT INC | 1,743,188 | $51,912,000 | 2.20% |
| Foundation Asset Management, LP | 255,790 | $7,617,000 | 2.19% |
| Proxima Capital Management, LLC | 550,000 | $16,379,000 | 1.93% |
| Roundview Capital LLC | 140,645 | $4,188,000 | 1.69% |
| BB BIOTECH AG | 933,244 | $27,792,000 | 1.32% |
| PERRY CAPITAL | 1,517,208 | $45,182,000 | 1.25% |